Innovation Pharmaceuticals Inc (IPIX)

[zandant]

Depends how fast they can move. From today's press release, it seems like they have some work to do before the trial starts. My guess would be no.


"...expected to enroll approximately 120 patients with moderate-to-severe COVID-19. The trial’s primary endpoint is time to sustained recovery through Day 29 based on the National Institute of Allergy and Infectious Diseases (NIAID) Adaptive COVID-19 Treatment Trial (ACTT) clinical status ordinal scale. The Company will now complete site initiation visits and contracts to add additional clinical sites to the study."